SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-125566
Filing Date
2023-12-13
Accepted
2023-12-13 07:08:08
Documents
14
Period of Report
2023-12-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332757d1_8k.htm   iXBRL 8-K 34971
2 EXHIBIT 99.1 tm2332757d1_ex99-1.htm EX-99.1 17470
6 GRAPHIC tm2332757d1_ex99-1img001.jpg GRAPHIC 4148
  Complete submission text file 0001104659-23-125566.txt   241339

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bdtx-20231213.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdtx-20231213_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdtx-20231213_pre.xml EX-101.PRE 22391
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2332757d1_8k_htm.xml XML 3332
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 231482959
SIC: 2836 Biological Products, (No Diagnostic Substances)